In situ sustained release hydrogel system delivering GLUT1 inhibitor and chemo-drug for cancer post-surgical treatment
Source abstract
Abstract
Systematic administration of small molecular drugs often suffered from the low efficacy and systemic toxicity in cancer therapy. In addition, application of single mode drug usually leads to unsatisfactory therapeutic outcomes. Currently, developing multimodal-drug combination strategy that acts on different pathways without increasing side effects remains great challenge. Here, we developed a hydrogel system that co-delivered glycolysis inhibitor apigenin and chemo-drug gemcitabine to realize combination strategy for combating cancer with minimal systemic toxicity. We demonstrated that this system can not only eliminate tumor cells in situ, but also induce abscopal effect on various tumor models. These results showed that our study provided a safe and effective strategy for clinical cancer treatment.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Cancer, Hypoxia, and Metabolism · Nanoplatforms for cancer theranostics · Cancer Research and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (44)
Show source-provided references
1. Cancer statistics10.3322/caac.21763 ↗
2. Spatiotemporal immune landscape of colorectal cancer liver metastasis at single-cell level10.1158/2159-8290.CD-21-0316 ↗
3. Updated epidemiology of gastrointestinal cancers in East Asia10.1038/s41575-022-00726-3 ↗
4. Review the role of extracellular vesicles in cancer10.1016/j.cell.2023.03.010 ↗
5. Global burden of primary liver cancer in 2020 and predictions to 204010.1016/j.jhep.2022.08.021 ↗
6. Nitrogen mustard therapy: use of methyl-bis(beta-chloroethyl)amine hydrochloride and tris(Beta-Chloroethyl)amine hydrochloride for hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders10.1001/jama.1946.02870380008004 ↗
7. Highly active antiretroviral therapy (HAART) for the treatment of infection with human immunodeficiency virus type 110.1016/S0753-3322(99)80063-8 ↗
8. Co-delivery of drugs and plasmid DNA for cancer therapy10.1016/j.addr.2015.10.014 ↗
9. The evolution of hematopoietic cells under cancer therapy10.1038/s41467-021-24858-3 ↗
10. Inflammation and tumor progression: signaling pathways and targeted intervention10.1038/s41392-021-00658-5 ↗
11. Mitochondrial TCA cycle metabolites control physiology and disease10.1038/s41467-019-13668-3 ↗
12. Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IκBα10.1016/j.cmet.2022.08.002 ↗
13. Flux regulation through glycolysis and respiration is balanced by inositol pyrophosphates in yeast10.1016/j.cell.2023.01.014 ↗
14. Transcriptional repression of aerobic glycolysis by OVOL2 in breast cancer
15. The Warburg effect: how does it benefit cancer cells?10.1016/j.tibs.2016.01.004 ↗
16. Cancer metabolism: looking forward10.1038/s41568-021-00378-6 ↗
17. CTLA-4 blockade drives loss of T(reg) stability in glycolysis-low tumours10.1038/s41586-021-03326-4 ↗
18. Mitochondrial RNA modifications shape metabolic plasticity in metastasis10.1038/s41586-022-04898-5 ↗
19. Targeting SLC7A11 improves efferocytosis by dendritic cells and wound healing in diabetes10.1038/s41586-022-05101-5 ↗
20. Fatty acid oxidation fuels glioblastoma radioresistance with CD47-mediated immune evasion10.1038/s41467-022-29137-3 ↗
21. Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments10.1016/j.ccell.2022.01.001 ↗
22. Targeting cancer metabolism in the era of precision oncology10.1038/s41573-021-00339-6 ↗
23. Demystifying traditional herbal medicine with modern approaches10.1038/nplants.2017.109 ↗
24. Synthetic biology strategies for microbial biosynthesis of plant natural products10.1038/s41467-019-09848-w ↗
25. Modulation of the tumor microenvironment by natural agents: implications for cancer prevention and therapy10.1016/j.semcancer.2020.05.009 ↗
26. Glycosylated modification of MUC1 maybe a new target to promote drug sensitivity and efficacy for breast cancer chemotherapy10.1038/s41419-022-05110-2 ↗
27. The CDK1/TFCP2L1/ID2 cascade offers a novel combination therapy strategy in a preclinical model of bladder cancer10.1038/s12276-022-00786-0 ↗
28. Apigenin suppresses the stem cell-like properties of triple-negative breast cancer cells by inhibiting YAP/TAZ activity10.1038/s41420-018-0124-8 ↗
29. Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer10.1016/j.canlet.2021.05.019 ↗
30. The effect of apigenin and chemotherapy combination treatments on apoptosis-related genes and proteins in acute leukaemia cell lines10.1038/s41598-022-11441-z ↗
31. The inhibition of GLUT1-induced glycolysis in macrophage by phloretin participates in the protection during acute lung injury10.1016/j.intimp.2022.109049 ↗
32. Ferritin-based nanocomposite hydrogel promotes tumor penetration and enhances cancer chemoimmunotherapy
33. In situ forming pH/ROS-responsive niche-like hydrogel for ultrasound-mediated multiple therapy in synergy with potentiating anti-tumor immunity10.1016/j.mattod.2023.03.025 ↗
34. In situ formed reactive oxygen species-responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy10.1126/scitranslmed.aan3682 ↗
35. A review on chitosan-based biomaterial as carrier in tissue engineering and medical applications10.1016/j.eurpolymj.2023.112059 ↗
36. Biodegradation, biodistribution and toxicity of chitosan10.1016/j.addr.2009.09.004 ↗
37. A dual-bioresponsive drug-delivery depot for combination of epigenetic modulation and immune checkpoint blockade
38. H2O2 self-producing single-atom nanozyme hydrogels as light-controlled oxidative stress amplifier for enhanced synergistic therapy by transforming "cold" tumors
39. Thermosensitive hydrogel releasing nitric oxide donor and anti-CTLA-4 micelles for anti-tumor immunotherapy10.1038/s41467-022-29121-x ↗
40. A tumor microenvironments-adapted polypeptide hydrogel/nanogel composite boosts antitumor molecularly targeted inhibition and immunoactivation
41. An overview of dynamic covalent bonds in polymer material and their applications10.1016/j.eurpolymj.2020.110094 ↗
42. Microwave-assisted rapid and green synthesis of Schiff bases using cashew shell extract as a natural acid catalyst10.1021/acsomega.2c05187 ↗
43. Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells10.1016/j.biopha.2018.04.072 ↗
44. Adjuvant nab-paclitaxel + gemcitabine in resected pancreatic ductal adenocarcinoma: results from a randomized, open-label, phase III trial10.1200/JCO.22.01134 ↗